A Remote Diet and Exercise Intervention for Surgical Patients With Prefrailty and Frailty During the COVID-19 Pandemic

Abstract

Objectives: To facilitate the success of surgical patients with prefrailty and frailty in meeting diet and exercise goals in the context of the COVID-19 pandemic, and to encourage patient satisfaction with remote care. Methods: In the setting of the COVID-19 pandemic, surgical patients with prefrailty and frailty were offered remote visits with a geriatrician and a remote diet and exercise coaching program. Results: The coaching participants set a mean of 37 (±15) individualized dietary goals and 17 (±11) individualized exercise goals. 75% of the coaching participants met at least 65% of their dietary goals and 75% met at least 50% of their exercise goals. All patients met at least one diet goal and at least one exercise goal. Patients endorsed high levels of satisfaction with the program. Discussion: Diet and exercise interventions for surgical patients with prefrailty and frailty have potential for adaptation to remote formats. Such interventions may facilitate patients’ meeting of individualized diet and exercise goals and may also encourage patient satisfaction.

Doctor and patient perceptions of sarcopenia in community-based primary care clinics: A questionnaire survey

“…Patients preferred regular text messages as the best way to practice exercise and nutritional management for sarcopenia regularly. Other studies have reported that patients prefer text messages to video calls (20). Regular text messages, which are more economical and easier than home visits or video calls, should be actively used in primary care clinics.…”

Personalized Dietary Intervention Based on Mediterranean Diet as a Complementary Strategy to Modify Gut Microbiome, Quality of Life and Outcomes in Patients with Metastatic Melanoma Treated with Immunotherapy: A Study Protocol

“…The potential effect of an MD-based nutritional intervention could result in a greater benefit compared to trials focusing only on one nutrient. Considering the issues learned from the COVID-19 pandemic [17], the main goal of our trial is to determine the effectiveness and applicability of a remote, personalized nutritional intervention based on the MD to increase the intake of micronutrients (flavones, anthocyanins, omega-3 fatty acids, vitamin D and fiber) previously associated with a positive response to immunotherapy. Additionally, there is a scarce body of literature discussing the intricate interplay between the microbiome and immune system, suggesting that specific microbiome signatures producing essential metabolites such as SCFAs may enhance the effectiveness of immunotherapy and regulate the activity of immune cells not only by triggering metabolic and epigenetic reprogramming but also by binding to cognate receptors on the surface of cells.…”